Prophylaxis and quality of life in patients with hemophilia A during routine treatment with ADVATE [antihemophilic factor (recombinant), plasma/albumin-free method] in Germany: a subgroup analysis of the ADVATE PASS post-approval, non-interventional study - Pollmann, H; Klamroth, R; Vidovic, N (Ann Hematol, 2013)
, et al.